Gyre Therapeutics Inc. (GYRE)
NASDAQ: GYRE
· Real-Time Price · USD
7.97
-0.10 (-1.24%)
At close: Jun 13, 2025, 3:59 PM
7.89
-1.00%
After-hours: Jun 13, 2025, 04:20 PM EDT
Gyre Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Product Revenue | 105.8M |
| Product Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 15.8M | 22.32M | 17.52M | 17.84M | 15.94M | 21.23M | 2.41M | 2.23M | 3.97M | 4.17M | 4.36M | 3.84M | 4.99M | 4.16M | 4.87M | 4.52M | 5.41M | 4.29M | 3.83M | 4.37M | 3.69M | 3.19M | 3.27M | 3.27M | 3.69M | 3.44M | 2.77M | 3.23M | 2.91M | 2.59M | 2.39M | 2.65M | 2.38M | 2.18M | 2.42M | 2.27M | 2.4M | 3.03M | 2.51M | 2.75M | 3.39M |
| Selling, General, and Administrative Revenue Growth | -29.23% | +27.38% | -1.77% | +11.91% | -24.91% | +781.60% | +8.22% | -43.95% | -4.68% | -4.54% | +13.50% | -23.03% | +19.93% | -14.48% | +7.77% | -16.52% | +26.30% | +11.79% | -12.31% | +18.42% | +15.56% | -2.26% | -0.06% | -11.31% | +7.02% | +24.37% | -14.11% | +10.67% | +12.68% | +8.16% | -9.91% | +11.47% | +9.27% | -10.14% | +6.73% | -5.14% | -20.88% | +20.69% | -8.70% | -18.90% | n/a |
| Research and Development Revenue | 3.1M | 3.71M | 2.77M | 3.35M | 2.18M | 46.79M | 415K | 318K | 588K | 660K | 803K | 1.87M | 9.7M | 16.14M | 20.35M | 15.39M | 17.01M | 14.56M | 12.25M | 12.91M | 13.26M | 10.79M | 9.93M | 11.11M | 12.03M | 8.24M | 5.58M | 3.89M | 3.77M | 3.56M | 3.81M | 3.4M | 2.06M | 3.11M | 3.4M | 2.75M | 2.29M | 1.77M | 1.49M | 642K | 2.34M |
| Research and Development Revenue Growth | -16.62% | +33.77% | -17.29% | +53.76% | -95.34% | +11174.59% | +30.50% | -45.92% | -10.91% | -17.81% | -57.08% | -80.72% | -39.86% | -20.72% | +32.25% | -9.55% | +16.88% | +18.83% | -5.09% | -2.70% | +22.89% | +8.72% | -10.66% | -7.62% | +45.98% | +47.78% | +43.35% | +3.13% | +5.90% | -6.41% | +11.88% | +65.02% | -33.77% | -8.36% | +23.40% | +20.38% | +29.45% | +18.84% | +131.46% | -72.56% | n/a |
| Sales and Marketing Revenue | 10.84M | 16.86M | 13.7M | 14.41M | 12.54M | 15.45M | 15.88M | 14.78M | 12.73M | 15.44M | 15.79M | 12.03M | 12.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue Growth | -35.68% | +23.05% | -4.96% | +14.93% | -18.84% | -2.69% | +7.43% | +16.14% | -17.55% | -2.26% | +31.34% | -5.37% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |